Acquired sideroblastic anaemia following progesterone therapy.
We report a case of acquired sideroblastic anaemia precipitated by progesterone. On two separate occasions, over 15 years apart, the patient developed sideroblastic anaemia with iron overload shortly after the administration of progesterone. No other cause for sideroblastic anaemia was found, and treatment with folic acid, pyridoxine or androgens corrected the anaemia. In both instances removal of the progestational agent led to prompt disappearance of the anaemia as well as the ringed sideroblasts. Using a two-phase liquid culture procedure in which human peripheral blood-derived progenitor cells undergo erythroid proliferation and differentiation, we demonstrated enhanced sensitivity of the patient's erythroid progenitors to progesterone. We conclude that progesterone should be added to the list of medications known to be associated with acquired sideroblastic anaemia.
Brodsky
R A
RA
Hematology Branch, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, Maryland.
Hasegawa
S
S
Fibach
E
E
Dunbar
C E
CE
Young
N S
NS
Rodgers
G P
GP
D000328:Adult; D000756:Anemia, Sideroblastic / Q000139:chemically induced* / Q000473:pathology; D001853:Bone Marrow / Q000473:pathology; D002454:Cell Differentiation / Q000187:drug effects; D002455:Cell Division / Q000187:drug effects; D002478:Cells, Cultured; D015672:Erythroid Precursor Cells / Q000187:drug effects; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D011374:Progesterone / Q000494:pharmacology; D045167:Progesterone Congeners / Q000009:adverse effects*
D045167:Progesterone Congeners; D011374:Progesterone